Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 156 entries
Sorted by: Best Match Show Resources per page
One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines.

Chemistry Central journal

El-Kalyoubi SA, Fayed EA, Abdel-Razek AS.
PMID: 29086842
Chem Cent J. 2017 Jul 19;11(1):66. doi: 10.1186/s13065-017-0294-0.

BACKGROUND: Uracil derivatives have a great attraction because they play an important role in pharmacological activities. Pyrimidodiazepines, lumazines, triazolopyrimidines and xanthines have significant wide spectrum activities including anticancer, antiviral as well as antimicrobial activities.RESULTS: A newly synthesized compounds pyrimido[4,5-b][1,...

Cite
El-Kalyoubi SA, Fayed EA, Abdel-Razek AS. One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. Chem Cent J. 2017;11(1):66doi: 10.1186/s13065-017-0294-0.
El-Kalyoubi, S. A., Fayed, E. A., & Abdel-Razek, A. S. (2017). One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. Chemistry Central journal, 11(1), 66. https://doi.org/10.1186/s13065-017-0294-0
El-Kalyoubi, Samar A, et al. "One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines." Chemistry Central journal vol. 11,1 (2017): 66. doi: https://doi.org/10.1186/s13065-017-0294-0
El-Kalyoubi SA, Fayed EA, Abdel-Razek AS. One pot synthesis, antimicrobial and antioxidant activities of fused uracils: pyrimidodiazepines, lumazines, triazolouracil and xanthines. Chem Cent J. 2017 Jul 19;11(1):66. doi: 10.1186/s13065-017-0294-0. PMID: 29086842; PMCID: PMC5517388.
Copy Download .nbib Format: NLM
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis.

International journal of hepatology

Omar M, Abdel-Razek W, Abo-Raia G, Assem M, El-Azab G.
PMID: 26550493
Int J Hepatol. 2015;2015:309042. doi: 10.1155/2015/309042. Epub 2015 Oct 13.

Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and...

Cite
Omar M, Abdel-Razek W, Abo-Raia G, et al. Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. Int J Hepatol. 2015;2015:309042doi: 10.1155/2015/309042.
Omar, M., Abdel-Razek, W., Abo-Raia, G., Assem, M., & El-Azab, G. (2015). Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. International journal of hepatology, 2015309042. https://doi.org/10.1155/2015/309042
Omar, Mahmoud, et al. "Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis." International journal of hepatology vol. 2015 (2015): 309042. doi: https://doi.org/10.1155/2015/309042
Omar M, Abdel-Razek W, Abo-Raia G, Assem M, El-Azab G. Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis. Int J Hepatol. 2015;2015:309042. doi: 10.1155/2015/309042. Epub 2015 Oct 13. PMID: 26550493; PMCID: PMC4621358.
Copy Download .nbib Format: NLM
Current neoadjuvant treatment options for HER2-positive breast cancer.

Biologics : targets & therapy

Abdel-Razeq H, Marei L.
PMID: 21847344
Biologics. 2011;5:87-94. doi: 10.2147/BTT.S22917. Epub 2011 Aug 09.

Approximately one quarter of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, the expression of which is associated with a relatively poor prognosis independent of other clinical and pathologic variables. Trastuzumab, a...

Cite
Abdel-Razeq H, Marei L. Current neoadjuvant treatment options for HER2-positive breast cancer. Biologics. 2011;5:87-94doi: 10.2147/BTT.S22917.
Abdel-Razeq, H., & Marei, L. (2011). Current neoadjuvant treatment options for HER2-positive breast cancer. Biologics : targets & therapy, 587-94. https://doi.org/10.2147/BTT.S22917
Abdel-Razeq, Hikmat, and Marei, Lina. "Current neoadjuvant treatment options for HER2-positive breast cancer." Biologics : targets & therapy vol. 5 (2011): 87-94. doi: https://doi.org/10.2147/BTT.S22917
Abdel-Razeq H, Marei L. Current neoadjuvant treatment options for HER2-positive breast cancer. Biologics. 2011;5:87-94. doi: 10.2147/BTT.S22917. Epub 2011 Aug 09. PMID: 21847344; PMCID: PMC3156251.
Copy Download .nbib Format: NLM
Electromagnetic navigational bronchoscopy for diagnosing peripheral lung lesions in lung transplant recipients: a single-center experience.

Journal of thoracic disease

Panchabhai TS, Biswas Roy S, Madan N, Abdelrazek H, Patel VJ, Walia R, Bremner RM.
PMID: 30233886
J Thorac Dis. 2018 Aug;10(8):5108-5114. doi: 10.21037/jtd.2018.07.81.

No abstract available.

Cite
Panchabhai TS, Biswas Roy S, Madan N, et al. Electromagnetic navigational bronchoscopy for diagnosing peripheral lung lesions in lung transplant recipients: a single-center experience. J Thorac Dis. 2018;10(8):5108-5114doi: 10.21037/jtd.2018.07.81.
Panchabhai, T. S., Biswas Roy, S., Madan, N., Abdelrazek, H., Patel, V. J., Walia, R., & Bremner, R. M. (2018). Electromagnetic navigational bronchoscopy for diagnosing peripheral lung lesions in lung transplant recipients: a single-center experience. Journal of thoracic disease, 10(8), 5108-5114. https://doi.org/10.21037/jtd.2018.07.81
Panchabhai, Tanmay S, et al. "Electromagnetic navigational bronchoscopy for diagnosing peripheral lung lesions in lung transplant recipients: a single-center experience." Journal of thoracic disease vol. 10,8 (2018): 5108-5114. doi: https://doi.org/10.21037/jtd.2018.07.81
Panchabhai TS, Biswas Roy S, Madan N, Abdelrazek H, Patel VJ, Walia R, Bremner RM. Electromagnetic navigational bronchoscopy for diagnosing peripheral lung lesions in lung transplant recipients: a single-center experience. J Thorac Dis. 2018 Aug;10(8):5108-5114. doi: 10.21037/jtd.2018.07.81. PMID: 30233886; PMCID: PMC6129924.
Copy Download .nbib Format: NLM
Wernicke's Encephalopathy 5 Years After a Whipple Procedure.

The Neurohospitalist

AbdelRazek M, Han C, Albrecht A, Elsadek L, Yadollahikhales G, Elsadek R.
PMID: 29623164
Neurohospitalist. 2018 Apr;8(2):NP3-NP4. doi: 10.1177/1941874417710878. Epub 2017 May 30.

No abstract available.

Cite
AbdelRazek M, Han C, Albrecht A, et al. Wernicke's Encephalopathy 5 Years After a Whipple Procedure. Neurohospitalist. 2017;8(2):NP3-NP4doi: 10.1177/1941874417710878.
AbdelRazek, M., Han, C., Albrecht, A., Elsadek, L., Yadollahikhales, G., & Elsadek, R. (2018). Wernicke's Encephalopathy 5 Years After a Whipple Procedure. The Neurohospitalist, 8(2), NP3-NP4. https://doi.org/10.1177/1941874417710878
AbdelRazek, Mahmoud, et al. "Wernicke's Encephalopathy 5 Years After a Whipple Procedure." The Neurohospitalist vol. 8,2 (2018): NP3-NP4. doi: https://doi.org/10.1177/1941874417710878
AbdelRazek M, Han C, Albrecht A, Elsadek L, Yadollahikhales G, Elsadek R. Wernicke's Encephalopathy 5 Years After a Whipple Procedure. Neurohospitalist. 2018 Apr;8(2):NP3-NP4. doi: 10.1177/1941874417710878. Epub 2017 May 30. PMID: 29623164; PMCID: PMC5882004.
Copy Download .nbib Format: NLM
Severe bullous skin diseases: analysis of seven children managed in a burns unit.

Annals of burns and fire disasters

Elkharaz S, Abdel-Razek EM, Eldin A, Abdel-Razek AM.
PMID: 21991048
Ann Burns Fire Disasters. 2006 Dec 31;19(4):180-7.

Patients suffering from considerable cutaneous loss must be treated under strict aseptic conditions and with positive pressure ventilation, which is available in burns units. The differentiation of severe bullous skin diseases remains a challenge for the clinician. We report...

Cite
Elkharaz S, Abdel-Razek EM, Eldin A, et al. Severe bullous skin diseases: analysis of seven children managed in a burns unit. Ann Burns Fire Disasters. 2006;19(4):180-7
Elkharaz, S., Abdel-Razek, E. M., Eldin, A., & Abdel-Razek, A. M. (2006). Severe bullous skin diseases: analysis of seven children managed in a burns unit. Annals of burns and fire disasters, 19(4), 180-7.
Elkharaz, S, et al. "Severe bullous skin diseases: analysis of seven children managed in a burns unit." Annals of burns and fire disasters vol. 19,4 (2006): 180-7.
Elkharaz S, Abdel-Razek EM, Eldin A, Abdel-Razek AM. Severe bullous skin diseases: analysis of seven children managed in a burns unit. Ann Burns Fire Disasters. 2006 Dec 31;19(4):180-7. PMID: 21991048; PMCID: PMC3188110.
Copy Download .nbib Format: NLM
Is toxoplasmosis a potential risk factor for liver cirrhosis?.

Asian Pacific journal of tropical medicine

Abd El-Rehim El-Henawy A, Abdel-Razik A, Zakaria S, Elhammady D, Saudy N, Azab MS.
PMID: 26522292
Asian Pac J Trop Med. 2015 Oct;8(10):784-91. doi: 10.1016/j.apjtm.2015.09.003. Epub 2015 Sep 25.

OBJECTIVE: To document Toxoplasma gondii (T. gondii) antibody status in patients with liver disease, blood samples were taken from 180 hepatic patients and 180 healthy controls.METHODS: Toxoplasma IgG antibody was detected using enzyme-linked immunosorbent assay and histopathological assessment of...

Cite
Abd El-Rehim El-Henawy A, Abdel-Razik A, Zakaria S, et al. Is toxoplasmosis a potential risk factor for liver cirrhosis?. Asian Pac J Trop Med. 2015;8(10):784-91doi: 10.1016/j.apjtm.2015.09.003.
Abd El-Rehim El-Henawy, A., Abdel-Razik, A., Zakaria, S., Elhammady, D., Saudy, N., & Azab, M. S. (2015). Is toxoplasmosis a potential risk factor for liver cirrhosis?. Asian Pacific journal of tropical medicine, 8(10), 784-91. https://doi.org/10.1016/j.apjtm.2015.09.003
Abd El-Rehim El-Henawy, Abeer, et al. "Is toxoplasmosis a potential risk factor for liver cirrhosis?." Asian Pacific journal of tropical medicine vol. 8,10 (2015): 784-91. doi: https://doi.org/10.1016/j.apjtm.2015.09.003
Abd El-Rehim El-Henawy A, Abdel-Razik A, Zakaria S, Elhammady D, Saudy N, Azab MS. Is toxoplasmosis a potential risk factor for liver cirrhosis?. Asian Pac J Trop Med. 2015 Oct;8(10):784-91. doi: 10.1016/j.apjtm.2015.09.003. Epub 2015 Sep 25. PMID: 26522292.
Copy Download .nbib Format: NLM
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients.

OncoTargets and therapy

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Ali BA, Ibrahim M, Rimawi D.
PMID: 29695917
Onco Targets Ther. 2018 Apr 11;11:2091-2096. doi: 10.2147/OTT.S151821. eCollection 2018.

BACKGROUND: The majority of breast cancer patients in Jordan are diagnosed at a young age and present with metastatic or locally advanced disease. The National Surgical Adjuvant Breast and Bowel Project Protocol B27 (NSABP-B27) (four cycles of adriamycin and...

Cite
Abdel-Razeq H, Saadeh SS, Abu-Nasser M, et al. Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients. Onco Targets Ther. 2018;11:2091-2096doi: 10.2147/OTT.S151821.
Abdel-Razeq, H., Saadeh, S. S., Abu-Nasser, M., Abdulelah, H., Marie, L., Salam, M., Ali, B. A., Ibrahim, M., & Rimawi, D. (2018). Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients. OncoTargets and therapy, 112091-2096. https://doi.org/10.2147/OTT.S151821
Abdel-Razeq, Hikmat, et al. "Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients." OncoTargets and therapy vol. 11 (2018): 2091-2096. doi: https://doi.org/10.2147/OTT.S151821
Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Ali BA, Ibrahim M, Rimawi D. Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients. Onco Targets Ther. 2018 Apr 11;11:2091-2096. doi: 10.2147/OTT.S151821. eCollection 2018. PMID: 29695917; PMCID: PMC5905529.
Copy Download .nbib Format: NLM
Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program.

Clinical liver disease

Abdel-Razek W, Hassany M, El-Sayed MH, El-Serafy M, Doss W, Esmat G, Waked I.
PMID: 32015869
Clin Liver Dis (Hoboken). 2020 Jan 29;14(6):203-206. doi: 10.1002/cld.868. eCollection 2019 Dec.

No abstract available.

Cite
Abdel-Razek W, Hassany M, El-Sayed MH, et al. Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program. Clin Liver Dis (Hoboken). 2020;14(6):203-206doi: 10.1002/cld.868.
Abdel-Razek, W., Hassany, M., El-Sayed, M. H., El-Serafy, M., Doss, W., Esmat, G., & Waked, I. (2019). Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program. Clinical liver disease, 14(6), 203-206. https://doi.org/10.1002/cld.868
Abdel-Razek, Wael, et al. "Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program." Clinical liver disease vol. 14,6 (2019): 203-206. doi: https://doi.org/10.1002/cld.868
Abdel-Razek W, Hassany M, El-Sayed MH, El-Serafy M, Doss W, Esmat G, Waked I. Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program. Clin Liver Dis (Hoboken). 2020 Jan 29;14(6):203-206. doi: 10.1002/cld.868. eCollection 2019 Dec. PMID: 32015869; PMCID: PMC6988418.
Copy Download .nbib Format: NLM
Physiological Roles of Red Carrot Methanolic Extract and Vitamin E to Abrogate Cadmium-Induced Oxidative Challenge and Apoptosis in Rat Testes: Involvement of the Bax/Bcl-2 Ratio.

Antioxidants (Basel, Switzerland)

Abdel-Wahab A, Hassanin KMA, Mahmoud AA, Abdel-Badeea WIE, Abdel-Razik AH, Attia EZ, Abdelmohsen UR, Abdel Aziz RL, Najda A, Alanazi IS, Alsharif KF, Abdel-Daim MM, Mahmoud MO.
PMID: 34829524
Antioxidants (Basel). 2021 Oct 21;10(11). doi: 10.3390/antiox10111653.

The precise analysis of the contents of the red carrot is still ambiguous and its role in the maintenance of male fertility needs to be further reconnoitered. Hence, this study targets the physiological impacts of either red carrot methanolic...

Cite
Abdel-Wahab A, Hassanin KMA, Mahmoud AA, et al. Physiological Roles of Red Carrot Methanolic Extract and Vitamin E to Abrogate Cadmium-Induced Oxidative Challenge and Apoptosis in Rat Testes: Involvement of the Bax/Bcl-2 Ratio. Antioxidants (Basel). 2021;10(11)doi: 10.3390/antiox10111653.
Abdel-Wahab, A., Hassanin, K. M. A., Mahmoud, A. A., Abdel-Badeea, W. I. E., Abdel-Razik, A. H., Attia, E. Z., Abdelmohsen, U. R., Abdel Aziz, R. L., Najda, A., Alanazi, I. S., Alsharif, K. F., Abdel-Daim, M. M., & Mahmoud, M. O. (2021). Physiological Roles of Red Carrot Methanolic Extract and Vitamin E to Abrogate Cadmium-Induced Oxidative Challenge and Apoptosis in Rat Testes: Involvement of the Bax/Bcl-2 Ratio. Antioxidants (Basel, Switzerland), 10(11), . https://doi.org/10.3390/antiox10111653
Abdel-Wahab, Ahmed, et al. "Physiological Roles of Red Carrot Methanolic Extract and Vitamin E to Abrogate Cadmium-Induced Oxidative Challenge and Apoptosis in Rat Testes: Involvement of the Bax/Bcl-2 Ratio." Antioxidants (Basel, Switzerland) vol. 10,11 (2021). doi: https://doi.org/10.3390/antiox10111653
Abdel-Wahab A, Hassanin KMA, Mahmoud AA, Abdel-Badeea WIE, Abdel-Razik AH, Attia EZ, Abdelmohsen UR, Abdel Aziz RL, Najda A, Alanazi IS, Alsharif KF, Abdel-Daim MM, Mahmoud MO. Physiological Roles of Red Carrot Methanolic Extract and Vitamin E to Abrogate Cadmium-Induced Oxidative Challenge and Apoptosis in Rat Testes: Involvement of the Bax/Bcl-2 Ratio. Antioxidants (Basel). 2021 Oct 21;10(11). doi: 10.3390/antiox10111653. PMID: 34829524; PMCID: PMC8615202.
Copy Download .nbib Format: NLM
Patterns and Prevalence of Germline .

Journal of oncology

Abdel-Razeq H, Abujamous L, Jadaan D.
PMID: 32733560
J Oncol. 2020 Jul 14;2020:8362179. doi: 10.1155/2020/8362179. eCollection 2020.

No abstract available.

Cite
Abdel-Razeq H, Abujamous L, Jadaan D. Patterns and Prevalence of Germline . J Oncol. 2020;2020:8362179doi: 10.1155/2020/8362179.
Abdel-Razeq, H., Abujamous, L., & Jadaan, D. (2020). Patterns and Prevalence of Germline . Journal of oncology, 20208362179. https://doi.org/10.1155/2020/8362179
Abdel-Razeq, Hikmat, et al. "Patterns and Prevalence of Germline ." Journal of oncology vol. 2020 (2020): 8362179. doi: https://doi.org/10.1155/2020/8362179
Abdel-Razeq H, Abujamous L, Jadaan D. Patterns and Prevalence of Germline . J Oncol. 2020 Jul 14;2020:8362179. doi: 10.1155/2020/8362179. eCollection 2020. PMID: 32733560; PMCID: PMC7376431.
Copy Download .nbib Format: NLM
A Cluster of Children with Facial Nerve Palsy in High Prevalence Area for COVID-19.

Public health in practice (Oxford, England)

Barron D, Richards O, Archer F, Abdelrazek M, Ranjan R, Omolokun O.
PMID: 34396357
Public Health Pract (Oxf). 2021 Aug 08;100173. doi: 10.1016/j.puhip.2021.100173. Epub 2021 Aug 08.

OBJECTIVES: COVID-19 is a disease of varying presentation and neurological sequelae of the disease are being studied. Following a cluster of paediatric facial nerve palsy (FNP) cases in an area of South Wales with a high prevalence of COVID-19,...

Cite
Barron D, Richards O, Archer F, et al. A Cluster of Children with Facial Nerve Palsy in High Prevalence Area for COVID-19. Public Health Pract (Oxf). 2021;100173doi: 10.1016/j.puhip.2021.100173.
Barron, D., Richards, O., Archer, F., Abdelrazek, M., Ranjan, R., & Omolokun, O. (2021). A Cluster of Children with Facial Nerve Palsy in High Prevalence Area for COVID-19. Public health in practice (Oxford, England), 100173. https://doi.org/10.1016/j.puhip.2021.100173
Barron, David, et al. "A Cluster of Children with Facial Nerve Palsy in High Prevalence Area for COVID-19." Public health in practice (Oxford, England) vol. (2021): 100173. doi: https://doi.org/10.1016/j.puhip.2021.100173
Barron D, Richards O, Archer F, Abdelrazek M, Ranjan R, Omolokun O. A Cluster of Children with Facial Nerve Palsy in High Prevalence Area for COVID-19. Public Health Pract (Oxf). 2021 Aug 08;100173. doi: 10.1016/j.puhip.2021.100173. Epub 2021 Aug 08. PMID: 34396357; PMCID: PMC8349358.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 156 entries